Banerjee Indrajit, Robinson Jared, Leclézio Alexandra, Sathian Brijesh, Banerjee Indraneel
Sir Seewoosagur Ramgoolam Medical College, Belle Rive, Mauritius.
Geriatrics and long term care Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Nepal J Epidemiol. 2022 Jun 30;12(2):1215-1219. doi: 10.3126/nje.v12i2.46149. eCollection 2022 Jun.
The global pandemic caused by the SARS-CoV-2 virus has affected every continent worldwide. The novelty of this virus, its mutations and the rapid speed and unprecedented rate at which it has torn through the global community has in turn lead to an innate lack of knowledge and information about the actual disease caused and the severity of the complications associated with COVID-19. The SARS-CoV-2 virus has been infecting individuals since 2019 and now as of 2022 has been circulating for just over 2 years within the global populous. As the number of cases have risen globally over this period (some of which having contracted the virus twice) further endeavours have been undertaken to better understand the pathogenesis and natural progression of the disease. A condition reported in some cases with extended bouts of sickness or symptoms following the initial infection with COVID was labelled "long COVID" towards the earlier phases of the pandemic (in the spring of 2020), but has only recently gained the global media and medical attention due to its affliction of more individuals on a global basis and has thus warranted further investigation. Long COVID is described as a persistent, long-term state of poor health following an infection with COVID-19. The effect of Long COVID is multisystemic in nature with a wide array of signs and symptoms. The most commonly reported clinical features of long COVID are: headaches, myalgia, chest pain, rashes, abdominal pain, shortness of breath, palpitations, anosmia, persistent cough, brain fogs, forgetfulness, depression, insomnia, fatigue and anxiety. This research aims to explore the symptomatology, pathophysiology as well as the treatment and prevention of Long COVID.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒引起的全球大流行已影响到世界各大洲。这种病毒的新颖性、其突变以及它在全球范围内迅速传播且前所未有的速度，反过来导致人们对其所引发的实际疾病以及与新冠肺炎相关并发症的严重程度先天缺乏了解和信息。自2019年以来，SARS-CoV-2病毒一直在感染个体，截至2022年，它已在全球人口中传播了两年多。在此期间，全球病例数不断上升（其中一些人感染了两次该病毒），人们进一步努力以更好地了解该疾病的发病机制和自然病程。在疫情早期阶段（2020年春季），一些在初次感染新冠病毒后出现长时间疾病发作或症状的病例被标记为“长新冠”，但直到最近，由于其在全球范围内影响了更多人，才受到全球媒体和医学界的关注，因此有必要进行进一步调查。长新冠被描述为感染新冠病毒后持续存在的长期健康不佳状态。长新冠的影响本质上是多系统的，有各种各样的体征和症状。长新冠最常报告的临床特征是：头痛、肌痛、胸痛、皮疹、腹痛、呼吸急促、心悸、嗅觉丧失、持续咳嗽、脑雾、健忘、抑郁、失眠、疲劳和焦虑。本研究旨在探讨长新冠的症状学、病理生理学以及治疗和预防方法。
